22 Jul University of Wisconsin Program for Advance Cell Therapy (UW PACT)
Jacques Galipeau, M.D., Associate Dean for Therapeutics Development
Oct. 7 | 9:45am | FLW Ballroom G
Madison, WI
(Private)
We specialize in conducting first-in-human clinical trials to de-risk advanced cell therapy leveraging UW Health expertise in clinical domains of excellence. We empower our academic and industry partners to translate scientific discoveries to cell therapies through FDA CBER investigational new drug (IND) application-enabling and Phase I/II clinical studies. We have expertise in utilization and optimization of partially and fully automated closed systems for advanced cell manufacturing and enrichment. We maintain and continuously improve our operating procedures and quality system to meet cell therapy-specific FDA CBER guidance for Phase I/II clinical trials.
